Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes.
暂无分享，去创建一个
Y. Lotan | M. Humphreys | B. Eisner | S. Matin | W. Sexton | A. Nieder | M. Bjurlin | H. Kaimakliotis | M. Quek | J. Gottlieb | R. Dickstein | J. Jacob | Katie S. Murray | A. Feldman | S. Woldu | Jennifer Linehan | C. Labbate | K. Rose | Saum Ghodoussipor | Michael O'Donnell